Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry
Authors
Keywords
Atrial fibrillation, Anticoagulant therapy, Ischemic stroke, Antiplatelet therapy, Stroke, Diabetes mellitus, Physicians, Data management
Journal
PLoS One
Volume 8, Issue 5, Pages e63479
Publisher
Public Library of Science (PLoS)
Online
2013-05-22
DOI
10.1371/journal.pone.0063479
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Racial Differences in the Prevalence of Atrial Fibrillation among Males
- (2015) Ann M. Borzecki et al. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
- The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study
- (2012) Christian Torp-Pedersen et al. THROMBOSIS AND HAEMOSTASIS
- International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD)
- (2011) Ajay K. Kakkar et al. AMERICAN HEART JOURNAL
- Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter
- (2011) John A. Cairns et al. CANADIAN JOURNAL OF CARDIOLOGY
- 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
- (2011) Valentin Fuster et al. CIRCULATION
- Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry
- (2011) P Gabriel Steg et al. HEART
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk?
- (2010) Peter J. Zimetbaum et al. AMERICAN JOURNAL OF MEDICINE
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- (2010) et al. EUROPEAN HEART JOURNAL
- The Global Registry of Acute Coronary Events, 1999 to 2009-GRACE
- (2010) K. A. A. Fox et al. HEART
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
- (2009) Gregory Y.H. Lip et al. CHEST
- Reasons for Undertreatment with Oral Anticoagulants in Frail Geriatric Outpatients with Atrial Fibrillation
- (2009) Linda R. Tulner et al. DRUGS & AGING
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis
- (2008) Shinya Goto et al. AMERICAN HEART JOURNAL
- Pharmacology and Management of the Vitamin K Antagonists
- (2008) Jack Ansell et al. CHEST
- Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation
- (2008) R. Nieuwlaat et al. EUROPEAN HEART JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More